Showing 1 - 10 of 27
Persistent link: https://www.econbiz.de/10010557847
Our results suggest that the high-level model is a dominant management strategy over the low-level model in all modelled scenarios. These findings indicate the need for effective primary care-based incentives to encourage general practices not only to employ practice nurses, but to better...
Persistent link: https://www.econbiz.de/10011000843
Depression is the most common mental health disorder and is recognized as a chronic disease characterized by multiple acute episodes/relapses. Although modelling techniques play an increasingly important role in the economic evaluation of depression interventions, comparatively little attention...
Persistent link: https://www.econbiz.de/10010548284
Persistent link: https://www.econbiz.de/10009562073
Modelling in economic evaluation is an unavoidable fact of life. Cohort-based state transition models are most common, though discrete event simulation (DES) is increasingly being used to implement more complex model structures. The benefits of DES relate to the greater flexibility around the...
Persistent link: https://www.econbiz.de/10010849015
Depression is the most common mental health disorder and is recognized as a chronic disease characterized by multiple acute episodes/relapses. Although modelling techniques play an increasingly important role in the economic evaluation of depression interventions, comparatively little attention...
Persistent link: https://www.econbiz.de/10010680798
Persistent link: https://www.econbiz.de/10010614409
Persistent link: https://www.econbiz.de/10005520498
Background: There remains uncertainty around the appropriate choice of adjuvant therapies to offer postmenopausal women with node-positive early breast cancer. Objective and study design: To present the results derived from a discrete event simulation (DES) model that compared tamoxifen plus...
Persistent link: https://www.econbiz.de/10005590280
Aromatase inhibitors (AIs) have been evaluated clinically in a wide range of breast cancer treatment settings. Although these agents appear to have clinical superiority, they are more expensive than the therapies (primarily tamoxifen) they have been compared with, thus economic evaluation is...
Persistent link: https://www.econbiz.de/10005590282